Overview
Today, as CEO and Board Member of Newel Health, I am leveraging the full spectrum of my executive, entrepreneurial, and R&D experience. My mission is to build and back the next generation of AI-enabled digital therapeutics.
We are actively developing a robust portfolio model centered on improving access to health and learning outcomes across neuroscience, cardio-metabolic, and pain care. This involves forging strong, strategic partnerships across the healthcare ecosystem and continuously using evidence loops to ensure our solutions are not only innovative but also deliver measurable impact and scale responsibly.
My Role
CEO & Board Member
Awards
Innovation Solution
Key Achievement
Key Achievement Leading a portfolio of AI-enabled Digital Therapeutics for Health & Education Access.
Focus Metrics
Portfolio Growth; Access Expansion; Clinical Validation; Strategic Partnerships; Responsible AI Integration.
ANALYSIS OF CHALLENGES AND LEARNING
The current challenge is navigating the complex regulatory and evidence generation requirements for AI/ML-driven medical devices in healthcare, while simultaneously focusing on patient access and reimbursement models. The core learning is the absolute necessity of responsible AI integration. The future of access hinges on applying data and AI responsibly to drive measurable outcomes and build trust across the healthcare ecosystem.